A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet
Sponsored by Takeda
About this trial
Last updated 7 months ago
Study ID
TAK-062-2001
Status
Completed
Type
Interventional
Phase
Phase 2
Placebo
Yes
Accepting
12+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 8 months ago
What is this trial about?
The main aim is to see how TAK-062 works to reduce celiac-related symptoms and improve
small intestinal damage due to gluten exposure, in participants with celiac disease (CeD)
attempting to maintain a gluten-free diet (GFD) in treated participants versus placebo
controls.
What are the participation requirements?
Inclusion Criteria
Both men and women can take part.
Must be 12 years and older. Adolescents aged 12 to 17 years, inclusive, will be enrolled in Cohort 2 of the study.
Must have biopsy-confirmed Celiac Disease.
Must be attempting to maintain a gluten-free diet for at least 12 months.
Additional entry criteria will be discussed with the study doctor.